Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,960.00
Bid: 1,969.00
Ask: 1,971.00
Change: 35.00 (1.82%)
Spread: 2.00 (0.102%)
Open: 1,937.00
High: 1,977.00
Low: 1,931.00
Prev. Close: 1,925.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Hikma And Hargreaves Lansdown Lead FTSE 100 Higher

Fri, 07th Aug 2020 08:56

(Alliance News) - Stock prices in London opened mixed on Friday, with the FTSE 100 managing to post mild gains after well-received earnings from Hikma Pharmaceuticals and Hargreaves Lansdown.

Investors were wary of US-China tensions after President Donald Trump signed an executive order barring US residents from doing any business with the Chinese parent companies of social media platforms TikTok and WeChat, citing national security concerns.

The UK flagship index was up 5.32 points, or 0.1%, at 6,032.26. The mid-cap FTSE 250 index was down 18.53 points, or 0.1%, at 17,460.85. The AIM All-Share index was flat at 916.53.

The Cboe UK 100 index was down 0.2% at 599.69. The Cboe 250 was down 0.3% at 14,828.68, and the Cboe Small Companies was flat at 9,212.65.

In mainland Europe, the CAC 40 in Paris was down 0.4%, while the DAX 30 in Frankfurt was off 0.1%.

"European markets surprisingly kept their cool on Friday morning, despite Donald Trump effectively banning TikTok and WeChat in the US. Giving companies 45 days to end all transactions with ByteDance and Tencent - the respective owners of the China-based apps - the president lobbed another tech grenade in his cold war with Beijing, almost guaranteeing some kind of retaliation from the rival superpower. But with the form and severity of that retaliation currently unknown, the markets managed to avoid a full-blown panic attack," commented Spreadex analyst Connor Campbell.

On the London Stock Exchange, Hikma Pharmaceuticals was the best blue-chip performer, up 7.0% after the generic drugmaker raised the annual sales outlook for its two main units and reported higher first-half profit.

For the half-year ended June 30, attributable profit came in at USD212 million, up 16% from USD185 million last year and revenue was USD1.13 billion, up 8% from USD1.05 billion.

Hikma said it expects 2020 revenue from the injectables business to be between USD950 million and USD980 million, from the previous forecast of growth in the low to mid-single digits.

In addition, Hikma raised the revenue outlook for its generics division to a range of USD720 million to USD760 million, from USD700 million to USD750 million previously.

Hikma raised its interim dividend 14% to 16.0 cents from 14.0 cents.

Hargreaves Lansdown was up 6.0% after the stockbroker said it delivered a strong annual performance, despite an external environment of persistent challenges.

The Bristol, England-based company, which offers an investment platform for retail investors, said assets under administration for the year to June 30 increased 5% year-on-year to GBP104.0 billion from GBP99.3 billion a year ago. Net new business inflows also rose 5% year-on-year to GBP7.7 billion from GBP7.3 billion.

Annual pretax profit jumped 24% to GBP378.3 million from GBP305.8 million profit a year ago. This included a gain on disposal of GBP38.8 million relating to FundsLibrary Ltd. Stripping out the exceptional disposal gain, pretax profit rose 11% year-on-year to GBP339.5 million.

Revenue rose 15% to GBP550.9 million from GBP480.5 million, driven by higher asset levels and record share dealing volumes seen in the second half of the year.

Following the strong performance, Hargreaves Lansdown raised its total dividend 11% to 54.9 pence from 42p.

Rightmove was up 4.0% as the property portal pointed to positive signs in the UK housing market going forward, despite posting a fall in interim profit.

Rightmove reported a drop in first-half profit and scrapped its dividend after the Covid-19 crisis prompted the property portal to offer discounts to its customers.

For the half-year to June 30, pretax profit dropped to GBP61.6 million, down from GBP108.1 million last year, as revenue fell to GBP94.8 million from GBP143.9 million. Average revenue per advertiser was down by 34% to GBP712 per month from GBP1,077 last year.

The company elected against paying an interim dividend, having paid out 2.8p last year.

However, Rightmove said stamp duty holidays offered by the UK government provided the potential for cautious optimism that housing transaction levels would increase from the low point in the second quarter.

"'Following the reopening of the housing market on 13 May housing market activity is at record levels, with evidence of new home hunters coming into the market with changing needs as they reassess their priorities and further incentivised by the temporary stamp duty holiday," Chief Executive Peter Brooks-Johnson said.

At the other end of the large-cap index, Rolls-Royce Holdings was down 2.0% after the Finacial Times reported US-based activist investor ValueAct sold its entire shareholding in the jet engine maker - citing two people familiar with the situation.

According to FT, ValueAct built a 10% stake in Rolls-Royce in 2015 after it issued a string of profit warnings. The UK engineering company is currently evaluating a GBP1.5 billion to GBP2 billion capital raise to help restore its balance sheet.

ValueAct started reducing its stake - which peaked in 2017 at 11% - after the departure of Rolls-Royce's chief operating officer Brad Singer in December.

The Japanese Nikkei 225 index closed down 0.4%. In China, the Shanghai Composite ended down 0.9%, while the Hang Seng index in Hong Kong is down 2.0%.

The pound was quoted at USD1.3107 Friday morning, lower from USD1.3137 at the London equities close Thursday. Sterling was easing from five-month highs versus the greenback attained after the Bank of England on Thursday said it was not planning to use negative interest rates in the immediate future.

The euro was priced at USD1.1838, soft from USD1.1845. Against the yen, the dollar was trading at JPY105.57, flat from JPY105.51 in London.

Brent oil was quoted at USD45.02 a barrel Friday morning, lower from USD45.37 at the London equities close Thursday.

Gold was priced at USD2,058.24 an ounce Friday, up from USD2,052.10 late Thursday.

Still to come, there is the closely-watched US jobs report for July at 1330 BST.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
5 Aug 2022 09:43

Barclays downgrades Hikma to 'equalweight' on Generics concerns

(Sharecast News) - Barclays downgraded Hikma Pharmaceuticals on Friday to 'equalweight' from 'overweight' and cut the price target to 1,750p from 2,250p as it said a lack of visibility in the generics division was a real concern.

Read more
5 Aug 2022 08:15

LONDON BRIEFING: London Stock Exchange benefits from market volatility

(Alliance News) - London Stock Exchange Group on Friday said results in the first half of 2022 improved, as this year's interim period had an extra month's worth of contribution from recent acquisition Refinitiv.

Read more
4 Aug 2022 17:05

LONDON MARKET CLOSE: Stocks shrug off BoE's UK recession warning

(Alliance News) - Stocks in London managed to end higher on Thursday despite a bleak warning from the Bank of England regarding to outlook for the UK economy as it jacked up rates by 50 basis points.

Read more
4 Aug 2022 12:09

LONDON MARKET MIDDAY: BoE hikes, expects UK recession in 4th quarter

(Alliance News) - London shares price made some gains on Thursday morning, though these fell well short of the market rise seen on mainland Europe, as traders in London showed signs of trepidation leading up to the Bank of England's interest rate decision.

Read more
4 Aug 2022 10:15

Hikma revenue flat, profits tumble in first half

(Sharecast News) - Hikma shares were tumbling on Thursday morning after the pharmaceuticals company reported flat group revenue in its first half, at $1.21bn, as it slashed its guidance on its lagging generics business.

Read more
4 Aug 2022 09:01

LONDON MARKET OPEN: FTSE 100 underperforms amid pre-BoE trepidation

(Alliance News) - The FTSE 100 underperformed European peers and traded sideways in early dealings on Thursday, with the Bank of England to take centre-stage during a week that so far has been dominated by tensions between the US and China.

Read more
4 Aug 2022 09:00

TOP NEWS: Hikma first half hit by stiff competition for Generics

(Alliance News) - Hikma Pharmaceuticals PLC shares suffered on Thursday, as it lowered annual guidance after a poor performance in its Generics business hit half-year profit.

Read more
4 Aug 2022 07:54

LONDON MARKET PRE-OPEN: Next and Serco up outlook but Hikma lowers

(Alliance News) - Stock prices in London are seen opening ever-so-slightly higher, falling short of the more convincing gains seen in Asia, with investors wary ahead of the latest Bank of England interest rate decision.

Read more
28 Jul 2022 16:06

UK earnings, trading statements calendar - next 7 days

Friday 29 July 
Allianz Technology Trust PLCHalf Year Results
Aston Martin Lagonda Global Holdings PLCHalf Year Results
AstraZeneca PLCHalf Year Results
Babcock International Group PLCFull Year Results
CMC Markets PLCTrading Statement
Croda International PLCHalf Year Results
Glencore PLCTrading Statement
Jupiter Fund Management PLCHalf Year Results
IMI PLCHalf Year Results
Impellam Group PLCHalf Year Results
Industrials REIT LtdTrading Statement
International Consolidated Airlines Group SAHalf Year Results
Intertek Group PLCHalf Year Results
Law Debenture Corp PLCHalf Year Results
Morgan Advanced Materials PLCHalf Year Results
NatWest Group PLCHalf Year Results
Premier Miton Global Renewables Trust PLCHalf Year Results
Rightmove PLCHalf Year Results
Shearwater Group PLCFull Year Results
Standard Chartered PLCHalf Year Results
Walker Crips Group PLCFull Year Results
YouGov PLCTrading Statement
Monday 1 August 
Ascential PLCHalf Year Results
Cranswick PLCQ1 Results
Dialight PLCHalf Year Results
GlobalData PLCHalf Year Results
HSBC Holdings PLCHalf Year Results
Hutchmed (China) LtdHalf Year Results
NAHL Group PLCTrading Statement
Pearson PLCHalf Year Results
Senior PLCHalf Year Results
Seraphine Group PLCFull Year Results
Spectris PLCHalf Year Results
XP Power PLCHalf Year Results
Tuesday 2 August 
BP PLCHalf Year Results
Capital & Counties Properties PLCHalf Year Results
Coats Group PLCHalf Year Results
Devro PLCHalf Year Results
Direct Line Insurance Group PLCHalf Year Results
Domino's Pizza Group PLCHalf Year Results
Fresnillo PLCHalf Year Results
Greggs PLCHalf Year Results
Keller Group PLCHalf Year Results
Man Group PLCHalf Year Results
Rotork PLCHalf Year Results
Sage Group PLCQ3 Results
Staffline Group PLCHalf Year Results
Synthomer PLCHalf Year Results
Travis Perkins PLCHalf Year Results
Virgin Money UK PLCQ3 Results
Wednesday 3 August 
Endeavour Mining PLCHalf Year Results
Ferrexpo PLCHalf Year Results
Hill & Smith Holdings PLCHalf Year Results
Hiscox LtdHalf Year Results
IP Group PLCHalf year Results
LSL Property Services PLCHalf Year Results
Taylor Wimpey PLCHalf Year Results
Thursday 4 August 
Coca-Cola Europacific Partners PLCHalf Year Results
ConvaTec Group PLCHalf Year Results
Evraz PLCHalf Year Results
Glencore PLCHalf Year Results
Gym Group PLCHalf Year Results
Hikma Pharmaceuticals PLCHalf Year Results
Meggitt PLCHalf Year Results
Mondi PLCHalf Year Results
Morgan Sindall Group PLCHalf Year Results
Next PLCTrading Statement
Pantheon International PLCFull Year Results
Revolution Beauty Group PLCFull Year Results
Rolls-Royce Holdings PLCHalf Year Results
ScS Group PLCTrading Statement
Secure Trust Bank PLCHalf Year Results
Serco Group PLCHalf Year Results
Spirent Communications PLCHalf Year Results
Tritax Big Box REIT PLCHalf Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
18 Jul 2022 09:46

LONDON BROKER RATINGS: Trio of downgrades for Fevertree; Admiral cut

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
13 Jul 2022 10:02

LONDON BROKER RATINGS: Jefferies likes Tyman; UBS cuts Beazley

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
25 May 2022 10:05

LONDON BROKER RATINGS: JPMorgan cuts Hikma; Liberum likes Trustpilot

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
25 May 2022 08:28

LONDON BRIEFING: M&S warns on cost hit to profit but is well placed

(Alliance News) - Marks & Spencer on Wednesday reported a swing to profit for the year ended April 2, but the clothing, homewares and food retailer cautioned on profit in the year ahead, amid the war in Ukraine and investment plans.

Read more
24 May 2022 10:29

IN BRIEF: Hikma Pharmaceuticals Chief Executive Siggi Olafsson resigns

Hikma Pharmaceuticals PLC - London-based pharmaceutical company - Says Siggi Olafsson has resigned as chief executive officer and from the board to "pursue other opportunities." Adds he will remain available to the company until he resigns on June 24. Olafsson was appointed as CEO in 2018. Before he joined Hikma, he was president of peer firm Actavis Generics until 2014 from 2012.

Read more
24 May 2022 08:24

LONDON BRIEFING: Barclays launches delayed GBP1 billion share buyback

(Alliance News) - Barclays said it will kick off a GBP1.00 billion share buyback programme on Tuesday. The programme, initially announced in February, had been delayed in March after the bank admitted it sold more financial products to investors than it was allowed to.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.